{"created":"2023-05-15T14:33:09.576746+00:00","id":42989,"links":{},"metadata":{"_buckets":{"deposit":"e6219c56-7d9e-4523-b5b5-46a607cd8a00"},"_deposit":{"created_by":1,"id":"42989","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"42989"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00042989","sets":["1"]},"author_link":["427758","427770","427760","427762","427768","427765","427759","427757","427767","427769","427764","427763","427766","427761"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2002-05","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"621","bibliographicPageStart":"616","bibliographicVolumeNumber":"25","bibliographic_titles":[{"bibliographic_title":"Biological & Pharmaceutical Bulletin"}]}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0918-6158","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yamamoto, Fumihiko"}],"nameIdentifiers":[{"nameIdentifier":"427757","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Aoki, Mizuho"}],"nameIdentifiers":[{"nameIdentifier":"427758","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Furusawa, Yoshiya"}],"nameIdentifiers":[{"nameIdentifier":"427759","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ando, Koichi"}],"nameIdentifiers":[{"nameIdentifier":"427760","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kuwabara, Yasuo"}],"nameIdentifiers":[{"nameIdentifier":"427761","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Masuda, Kouji"}],"nameIdentifiers":[{"nameIdentifier":"427762","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sasaki, Shigeki"}],"nameIdentifiers":[{"nameIdentifier":"427763","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Maeda, Minoru"}],"nameIdentifiers":[{"nameIdentifier":"427764","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"青木 瑞穂","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"427765","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"古澤 佳也","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"427766","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"安藤 興一","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"427767","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"増田 康治","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"427768","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"佐々木 茂貴","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"427769","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"前田 稔","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"427770","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Synthesis and evaluation of 4-Bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targetting imaging agent","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Synthesis and evaluation of 4-Bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targetting imaging agent"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2002-07-18"},"publish_date":"2002-07-18","publish_status":"0","recid":"42989","relation_version_is_last":true,"title":["Synthesis and evaluation of 4-Bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targetting imaging agent"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-16T00:32:35.635952+00:00"}